AASLD News

As the House and Senate get ready to go on their traditional August recess, we have seen the first signs of movement in the congressional appropriations process. The House Appropriations Committee has released 10 of its 12 FY22 bills, seven of which have been combined into a single bill and passed the House on July 29. Those seven bills include funding for NIH, CDC, HRSA, and the VA. The good news

On World Hepatitis Day, July 28, 2021, AASLD joins colleagues and community voices around the world with an urgent call to action for Hepatitis Elimination by 2030 because “Hepatitis Can’t Wait.”

AASLD is pleased to announce the election of new Governing Board and Foundation Board members who will begin their terms in January 2022. The 2021 Nominating Committee met on April 6, 2021 and selected finalists for the positions of Councilor, Secretary, Foundation Board Trustee, Councilor-at-Large and members of the 2022 Nominating Committee.

The American Association for the Study of Liver Diseases acknowledges the passing of one of its members who made major contributions to our field. Roberto Groszmann, MD, FRCP passed away in New Haven on January 16, 2021.

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the rate of new hepatocellular carcinoma (HCC) cases has slowed since 2009, but only in urban areas.

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that in 2019, more than 500,000 persons died of hepatitis B virus infection, highlighting the urgent need for universal HBV vaccination of children beginning at birth, and scaling up testing and access to care and treatment before people with

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases (AASLD)– found that among pregnant women with hepatitis C virus (HCV), more than 25 percent were initially diagnosed during pregnancy screenings, which

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the distribution of a person’s body fat affects coronary heart disease risk, with an increased risk of heart events among people with a combination of high visceral adipose tissue (VAT) – abdominal fat─ and low liver fat.

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org ALEXANDRIA, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the burden of cirrhosis in women in North America has increased substantially in recent years, a worrying trend driven by a rise in alcohol

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that U.S. states that took part in the Affordable Care Act’s Medicaid expansion, which extended health care coverage to more low-income citizens

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that using neural networks, a type of machine learning algorithm, is a more accurate model for predicting waitlist mortality in liver transplantation

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that ursodeoxycholic acid (UDCA) treatment has significant, positive results for patients with primary sclerosing cholangitis (PSC), including

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that COVID-19 coagulation impairment, driven in part by endothelial Factor VIII, is associated with liver injury in infected patients.

Today the American Association for the Study of Liver Diseases (AASLD) announced that Hepatology Communications – AASLD’s free, open-access journal – has been accepted into Clarivate’s Science Citation Index Expanded (SCIE) and Journal Citation Reports – one of the leading citation indexes for journals of science and technology. The journal will now be eligible for an Impact Factor (IF) evaluation